Abstract

Peptidoglycan (PG) is an essential net-like macromolecule that surrounds bacteria, gives them their shape, and protects them against their own high osmotic pressure. PG synthesis inhibition leads to bacterial cell lysis, making it an important target for many antibiotics. The final two reactions in PG synthesis are performed by penicillin-binding proteins (PBPs). Their glycosyltransferase (GT) activity uses the lipid II precursor to synthesize glycan chains and their transpeptidase (TP) activity catalyzes the cross-linking of two glycan chains via the peptide side chains. Inhibition of either of these two reactions leads to bacterial cell death. β-lactam antibiotics target the transpeptidation reaction while antibiotic therapy based on inhibition of the GTs remains to be developed. Ongoing research is trying to fill this gap by studying the interactions of GTs with inhibitors and substrate mimics and utilizing the latter as templates for the design of new antibiotics. In this review we present an updated overview on the GTs and describe the structure-activity relationship of recently developed synthetic ligands.

Highlights

  • Peptidoglycan (PG) is an essential net-like macromolecule that surrounds bacteria, gives them their shape, and protects them against their own high osmotic pressure

  • PEPTIDOGLYCAN BIOSYNTHESIS The emergence of multidrug-resistant bacteria causes major public health problems, in medical facilities where the lack of efficient antibiotics could jeopardize the advances made in the treatment of many diseases

  • SUBSTRATE ANALOGS Besides moenomycin, which competes for the donor site of the GTs with the elongating glycan chain, the only known ligand that binds to the acceptor site of the GTs is the lipid II substrate

Read more

Summary

Introduction

Peptidoglycan (PG) is an essential net-like macromolecule that surrounds bacteria, gives them their shape, and protects them against their own high osmotic pressure. Chain elongation occurs in a processive way after each cycle, the lipid-bound glycan chain product must move to the donor site, probably thanks to the higher number of interactions that surround the pyrophosphate group and the sugar moieties in the donor site than in the acceptor site (Huang et al, 2012).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call